SKSanggu Kim

Sanggu Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sanggu Kim has a total of 112 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Germinal Centers Function as Macromolecular Sanctuaries that Protect Follicular T Cells from Immunotoxin-Mediated Depletion

    by Shihyoung Kim, Rajni Kant Shukla, Sarah Golconda, Hannah Yu, John C. Reneau, Namal P. M. Liyanage, Walter Hanel, Sanggu Kim

    Targeted lymphodepletion with CD3 immunotoxins (CD3-ITs) is promising for transplantation and T-cell malignancies, but incomplete tissue depletion limits efficacy. We used a murine anti-CD3 immunotoxin model, intravascular staining, histology, and CD4-iDTR mice to define factors associated with survival of follicular T cells. CD3-IT caused profound systemic T-cell depletion and enrichment of follicular helper (T FH ) and follicular regulatory (T FR ) T cells among surviving CD4 + cells in spleen, Peyer’s patches, and lymph nodes. Ex vivo, CXCR5 + T cells bound CD3-IT comparably to CXCR5 - cells and showed similar susceptibility to CD3-IT-mediated cytotoxicity (IC 50 , 0.471–0.569 nM). In contrast, within the splenic parenchyma, CXCR5 + T cells bound CD3-IT at approximately half the level of CXCR5 − counterparts ( p < 0.05). Histologically, CD3-IT depleted 83% of T cells in splenic T-cell zones, whereas GC T cells were relatively spared. Fc-silent anti-CD40L pretreatment disrupted GC architecture and was associated with a marked reduction in the phenotypic T FH compartment after CD3-IT treatment. In CD4-iDTR mice, free diphtheria toxin (DT) and CD3-IT produced substantially less depletion of GC than T-cell-zone T cells, whereas Fc-silent anti-CD3 mAb down-modulated CD3 on GC-T FH cells. BrdU incorporation did not indicate disproportionate GC-T FH proliferation, and relative sparing with both a 58-kDa free DT and a 278-kDa CD3-IT indicates that size alone is insufficient to explain the effect in intact germinal centers in vivo . Together, these data show that intact GC architecture creates a functional barrier to toxin-mediated depletion of resident follicular T cells.

  • Open Access

    CLAE: A High‐Fidelity Nanopore Sequencing Strategy for Read‐Level Viral Variant Detection and Environmental RNA Virus Discovery

    by Hannah Yu, Sarah Golconda, Ga‐Eun Lee, Dantong Xue, Guillermo Domínguez‐Huerta, James M. Wainaina, Benjamin Bolduc, Shashanka Murthy, Shihyoung Kim, Seth Faith, et al.

    High‐fidelity (HF) long‐read sequencing enables accurate profiling of microorganisms and pathogens at single‐molecule resolution. However, current Oxford Nanopore Technologies (ONT)—a revolutionary platform offering real‐time, portable sequencing at relatively low instrumental cost—suffer from severe read‐length bias, limited accuracy (often <Q20), and low throughput. Here, Circular‐ and Linear‐Amplicon‐Mediated Error Correction (CLAE) is introduced, a biochemical and computational approach that addresses these limitations by integrating hairpin ligation, pre‐circling, single‐stranded DNA linearization, and targeted nickase‐based debranching. CLAE significantly enhances rolling‐circle amplification (RCA) efficiency for long DNA templates, markedly improving Nanopore sequencing yield and accuracy. CLAE achieves Q30‐level accuracy in up to 27% of RCA reads, throughput exceeding 800 Mb per 100 pores, and an N50 of ≈15 Kb (bacterial genome). Moreover, its bidirectional subreads and high throughput substantially boost accuracy without compromising read length. CLAE is validated by resolving SARS‐CoV‐2 quasi‐species from community wastewater and recovering novel, full‐length RNA virus genomes from marine samples. CLAE enables precise variant detection in complex samples and corrects short‐read misassemblies, significantly broadening ONT's utility in metaviromics, epidemiology, and environmental surveillance. Thus, CLAE establishes a versatile, field‐compatible platform for high‐fidelity viral genome sequencing in targeted and agnostic contexts.


  • Open Access

    YTHDF1 and YTHDC1 m 6 A reader proteins regulate HTLV-1 tax and hbz activity

    by Emily M. King, Amanda Midkiff, Karsyn McClain, Sanggu Kim, Amanda R. Panfil

    Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus responsible for adult T-cell leukemia/lymphoma (ATLL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a progressive neurodegenerative disease. Regulation of viral gene expression plays a key role in viral persistence and pathogenesis. However, the molecular mechanisms underlying this fine-tuned regulation remain poorly understood. Little is known regarding RNA chemical modifications of HTLV-1 RNA and how these affect viral biology and disease development. Post-transcriptional chemical modification of RNA is common in eukaryotes, with N 6 -methyladenosine (m 6 A) being the most prevalent. In this study, we investigated the role of m 6 A RNA modifications on HTLV-1 gene expression. Using MeRIP-Seq, we mapped the sites of m 6 A modification to the 3’ end of the viral genome. We found HTLV-1 RNA, as well as viral oncogene transcripts tax and hbz , contained m 6 A modifications. m 6 A-depletion in HTLV-1-transformed cells decreased sense-derived viral genes ( Tax, Gag, and Env ) and increased antisense-derived Hbz expression. Tax and hbz transcripts were bound by reader proteins YTHDF1 and YTHDC1 in a panel of HTLV-1 T-cell lines. Using expression vectors and shRNA-mediated knockdown, we found that YTHDF1 had opposing effects on viral gene expression, decreasing sense-derived viral genes and increasing antisense-derived Hbz . Upon further study, the YTHDF1 effects on tax abundance were dependent on tax m 6 A deposition. The nuclear m 6 A reader protein YTHDC1 affected the abundance of both sense- and antisense-derived viral transcripts and specifically enhanced the nuclear export of tax transcript. Collectively, our results demonstrate global m 6 A levels and m 6 A reader proteins YTHDF1 and YTHDC1 regulate HTLV-1 gene expression. IMPORTANCE: Human T-cell leukemia virus type 1 (HTLV-1) persistence and pathogenesis are controlled through tight regulation of viral gene expression. The fate of RNA can be controlled by epigenetic modifications that impact gene expression without altering the DNA sequence. Our study details the impact of N6-methyladenosine (m 6 A) RNA chemical modifications on HTLV-1 gene expression. We found that reductions in global m 6 A levels affected viral gene expression, decreasing Tax and other sense-derived viral genes, whereas increasing the antisense-derived Hbz . Our results suggest the oncogenic viral transcripts, tax and hbz , are m 6 A-modified in cells. We found that these viral RNA modifications are interpreted by reader proteins YTHDF1 and YTHDC1, which dictate the fate of the viral RNA. Understanding HTLV-1 RNA chemical modifications offers potential insights into novel therapeutic strategies for HTLV-1-associated diseases.


  • Top Cited Papers
    Open Access

    Single-molecule epitranscriptomic analysis of full-length HIV-1 RNAs reveals functional roles of site-specific m6As

    by Alice Baek, Ga-Eun Lee, Sarah Golconda, Asif Rayhan, Anastasios A. Manganaris, Shuliang Chen, Nagaraja Tirumuru, Hannah Yu, Shihyoung Kim, Christopher Kimmel, et al.

    Although the significance of chemical modifications on RNA is acknowledged, the evolutionary benefits and specific roles in human immunodeficiency virus (HIV-1) replication remain elusive. Most studies have provided only population-averaged values of modifications for fragmented RNAs at low resolution and have relied on indirect analyses of phenotypic effects by perturbing host effectors. Here we analysed chemical modifications on HIV-1 RNAs at the full-length, single RNA level and nucleotide resolution using direct RNA sequencing methods. Our data reveal an unexpectedly simple HIV-1 modification landscape, highlighting three predominant N6-methyladenosine (m6A) modifications near the 3′ end. More densely installed in spliced viral messenger RNAs than in genomic RNAs, these m6As play a crucial role in maintaining normal levels of HIV-1 RNA splicing and translation. HIV-1 generates diverse RNA subspecies with distinct m6A ensembles, and maintaining multiple of these m6As on its RNAs provides additional stability and resilience to HIV-1 replication, suggesting an unexplored viral RNA-level evolutionary strategy.


  • Open Access

    Mapping m6A Sites on HIV-1 RNA Using Oligonucleotide LC-MS/MS

    by Alice Baek, Asif Rayhan, Ga-Eun Lee, Sarah Golconda, Hannah Yu, Shihyoung Kim, Patrick A. Limbach, Balasubrahmanyam Addepalli, Sanggu Kim

    The biological significance of chemical modifications to the ribonucleic acid (RNA) of human immunodeficiency virus type-1 (HIV-1) has been recognized. However, our understanding of the site-specific and context-dependent roles of these chemical modifications remains limited, primarily due to the absence of nucleotide-resolution mapping of modification sites. In this study, we present a method for achieving nucleotide-resolution mapping of chemical modification sites on HIV-1 RNA using liquid chromatography and tandem mass spectrometry (LC–MS/MS). LC–MS/MS, a powerful tool capable of directly analyzing native RNAs, has proven effective for mapping RNA modifications in small RNA molecules, including ribosomal RNA and transfer RNA. However, longer RNAs have posed challenges, such as the 9 Kb HIV-1 virion RNA, due to the complexity of and ambiguity in mass differences among RNase T1-cleaved RNA fragments in LC-MS/MS data. Here, we introduce a new target RNA enrichment method to isolate small local RNA fragments of HIV-1 RNA that potentially harbor site-specific N6-methyladenosine (m6A) modifications. In our initial trial, we used target-specific DNA probes only and encountered insufficient RNA fragmentation due to inefficient S1 digestion near the target site. Recognizing that inefficient S1 digestion by HIV-1 RNA is likely due to the formation of secondary structures in proximity to the target site, we designed multiple DNA probes annealing to various sites of HIV-1 RNA to better control the structures of RNA substrates for S1 digestion. The use of these non-target DNA probes significantly improved the isolation of more homogeneous target RNA fragments of approximately 50 bases in length. Oligonucleotide LC-MS/MS analysis of these isolated target RNA fragments successfully separated and detected both m6A-methylated and non-methylated oligomers at the two m6A-predicted sites. The principle of this new target enrichment strategy holds promise and should be broadly applicable to the analysis of any lengthy RNA that was previously deemed infeasible for investigation using oligonucleotide LC-MS/MS.


  • Open Access

    CD3-immunotoxin mediated depletion of T cells in lymphoid tissues of rhesus macaques

    by Lan Wang, Gajendra W. Suryawanshi, Shihyoung Kim, Xin Guan, Aylin C. Bonifacino, Mark E. Metzger, Robert E. Donahue, Sanggu Kim, Irvin S.Y. Chen


  • Open Access

    Single-RNA-level analysis of full-length HIV-1 RNAs reveals functional redundancy of m6As

    by Alice Baek, Ga-Eun Lee, Sarah Golconda, Asif Rayhan, Anastasios Manganaris, Shuliang Chen, Nagaraja Tirumuru, Hannah Yu, Shihyoung Kim, Christopher Kimmel, et al.

    HIV-1 exploits every aspect of RNA, a versatile macromolecule that undergoes various post-transcriptional modifications, to maximize its replication. Although the importance of chemical modifications on RNA has been recognized, their evolutionary benefits and precise roles in HIV-1 replication remain unclear. Most studies have provided only population-averaged values of modifications for fragmented RNAs at low resolution and have relied on indirect analyses of the phenotypic effects of perturbing host effectors, neglecting site-specificity and intra-RNA heterogeneity1–9. Here, we developed a new RNA-library-preparation method for full-length direct RNA sequencing and analyzed HIV-1-specific modifications at the single-RNA level. Our analysis revealed that the HIV-1 modification landscape is unexpectedly simple, showing three predominant N6-methyladenosine (m6A) modifications near the 3' end. More densely installed in viral mRNAs than in genomic RNAs, these m6As play a crucial role in maintaining normal levels of RNA splicing and translation. We also discovered that HIV-1 generates diverse RNA subspecies with distinct ensembles of the m6As and that these m6As regulate splicing independently of each other. Our single-RNA-level study demonstrates that HIV-1 tolerates functionally redundant m6As to provide stability and resilience to viral replication while minimizing the risk of unpredictable mutagenesis – a novel RNA-level strategy similar to bet-hedging in evolutionary biology.


  • Open Access

    CD3e-immunotoxin spares CD62Llo Tregs and reshapes organ-specific T-cell composition by preferentially depleting CD3ehi T cells

    by Shihyoung Kim, Rajni Kant Shukla, Hannah Yu, Alice Baek, Sophie G. Cressman, Sarah Golconda, Ga-Eun Lee, Hyewon Choi, John C. Reneau, Zhirui Wang, et al.

    CD3-epsilon(CD3e) immunotoxins (IT), a promising precision reagent for various clinical conditions requiring effective depletion of T cells, often shows limited treatment efficacy for largely unknown reasons. Tissue-resident T cells that persist in peripheral tissues have been shown to play pivotal roles in local and systemic immunity, as well as transplant rejection, autoimmunity and cancers. The impact of CD3e-IT treatment on these local cells, however, remains poorly understood. Here, using a new murine testing model, we demonstrate a substantial enrichment of tissue-resident Foxp3+ Tregs following CD3e-IT treatment. Differential surface expression of CD3e among T-cell subsets appears to be a main driver of Treg enrichment in CD3e-IT treatment. The surviving Tregs in CD3e-IT-treated mice were mostly the CD3edimCD62Llo effector phenotype, but the levels of this phenotype markedly varied among different lymphoid and nonlymphoid organs. We also found notable variations in surface CD3e levels among tissue-resident T cells of different organs, and these variations drive CD3e-IT to uniquely reshape T-cell compositions in local organs. The functions of organs and anatomic locations (lymph nodes) also affected the efficacy of CD3e-IT. The multi-organ pharmacodynamics of CD3e-IT and potential treatment resistance mechanisms identified in this study may generate new opportunities to further improve this promising treatment.


  • Open Access

    CD3e-immunotoxin spares CD62L lo Tregs and reshapes organ-specific T-cell composition by preferentially depleting CD3e hi T cells

    by Shihyoung Kim, Rajni Kant Shukla, Hannah Yu, Alice Baek, Sophie G Cressman, Sarah Golconda, Ga-Eun Lee, Hyewon Choi, John C Reneau, Zhirui Wang, et al.

    CD3-epsilon(CD3e) immunotoxins (IT), a promising precision reagent for various clinical conditions requiring effective depletion of T cells, often shows limited treatment efficacy for largely unknown reasons. Tissue-resident T cells that persist in peripheral tissues have been shown to play pivotal roles in local and systemic immunity, as well as transplant rejection, autoimmunity and cancers. The impact of CD3e-IT treatment on these local cells, however, remains poorly understood. Here, using a new murine testing model, we demonstrate a substantial enrichment of tissue-resident Foxp3+ Tregs following CD3e-IT treatment. Differential surface expression of CD3e among T-cell subsets appears to be a main driver of Treg enrichment in CD3e-IT treatment. The surviving Tregs in CD3e-IT-treated mice were mostly the CD3e dim CD62L lo effector phenotype, but the levels of this phenotype markedly varied among different lymphoid and nonlymphoid organs. We also found notable variations in surface CD3e levels among tissue-resident T cells of different organs, and these variations drive CD3e-IT to uniquely reshape T-cell compositions in local organs. The functions of organs and anatomic locations (lymph nodes) also affected the efficacy of CD3e-IT. The multi-organ pharmacodynamics of CD3e-IT and potential treatment resistance mechanisms identified in this study may generate new opportunities to further improve this promising treatment.

  • Open Access

    Comparison of CD3e Antibody and CD3e-sZAP Immunotoxin Treatment in Mice Identifies sZAP as the Main Driver of Vascular Leakage

    by Shihyoung Kim, Rajni Kant Shukla, Eunsoo Kim, Sophie G. Cressman, Hannah Yu, Alice Baek, Hyewon Choi, Alan Kim, Amit Sharma, Zhirui Wang, et al.

    Anti-CD3-epsilon (CD3e) monoclonal antibodies (mAbs) and CD3e immunotoxins (ITs) are promising targeted therapy options for various T-cell disorders. Despite significant advances in mAb and IT engineering, vascular leakage syndrome (VLS) remains a major dose-limiting toxicity for ITs and has been poorly characterized for recent “engineered” mAbs. This study undertakes a direct comparison of non-mitogenic CD3e-mAb (145-2C11 with Fc-silentTM murine IgG1: S-CD3e-mAb) and a new murine-version CD3e-IT (saporin–streptavidin (sZAP) conjugated with S-CD3e-mAb: S-CD3e-IT) and identifies their distinct toxicity profiles in mice. As expected, the two agents showed different modes of action on T cells, with S-CD3e-mAb inducing nearly complete modulation of CD3e on the cell surface, while S-CD3e-IT depleted the cells. S-CD3e-IT significantly increased the infiltration of polymorphonuclear leukocytes (PMNs) into the tissue parenchyma of the spleen and lungs, a sign of increased vascular permeability. By contrast, S-CD3e-mAbs-treated mice showed no notable signs of vascular leakage. Treatment with control ITs (sZAP conjugated with Fc-silent isotype antibodies) induced significant vascular leakage without causing T-cell deaths. These results demonstrate that the toxin portion of S-CD3e-IT, not the CD3e-binding portion (S-CD3e-mAb), is the main driver of vascular leakage, thus clarifying the molecular target for improving safety profiles in CD3e-IT therapy.